Rules that exempt drugs from Medicare negotiation if there’s ‘meaningful’ generic competition could whittle down the effect of the program.
corporate power
Corporate Capture in California
The state DMV went to extreme lengths to shield Waymo from having to release any information about how it obtained permits for self-driving taxis in San Francisco.
As Auto Workers Contract Talks Heat Up, Stellantis Threatens to Move South
Capital flight is playing a major role in the UAW negotiations, with U.S. plants at risk of losing work to Mexico being used as leverage.
Google Tries to Protect Its Monopoly Under Cover of Darkness
The search giant objects to a live audio feed of its historic monopolization trial, which begins next week.
The Revolving Door Threatens the Integrity of the U.S. Patent and Trademark Office
The Trump-era Patent Office director has expanded his post-government influence-peddling.
It’s Time for Biden to Start Naming Names
Today on TAP: As Republicans run against corporate ‘wokeness,’ he should run against corporate (CEOs’, big-time investors’) greed.
Big Ag Opens Another Vein of Public Funding
Money from the Climate-Smart Commodities program, designed to reduce agriculture emissions, is going disproportionately to multinationals.
American Steel’s Succession
Mergers temporarily strengthen labor’s bargaining chip. But in the long run, anti-monopoly experts say, corporate power crushes workers and consumers.
Medicare Price Negotiation: Ten Drugs That Made the List, and Ten That Should Have
Advocates were thrilled that Medicare will negotiate the price of several insulins. But other high-profit drugs are protected by the new program’s rules.
How Private Monopolies Fuel Climate Disaster and Public Corruption
Investor-owned utilities have been at the forefront of numerous political scandals and ecological disasters. There is an alternative.

